12:54 PM EDT, 04/07/2025 (MT Newswires) -- Bausch Health ( BHC ) will report fiscal first-quarter results after market close on April 30, following Bausch + Lomb's first-quarter results (before market open) on the same day.

RBC estimates first-quarter revenue of US$2.24 billion and adj. EBITDA of US$720 million. Following the announced debt refinancing (52.5% of BLCO equity is pledged), RBC's Douglas Miehm will seek management's commentary for the path to value-unlocking of the Bausch + Lomb equity stake (~88% BLCO equity). Miehm will also seek updates on Xifaxan, including the ongoing litigation and updated commentary on the impact from the announced tariffs.

Target lowered to US$8.50, from US$9. Maintain Sector Perform.

Price: 7.18, Change: -0.40, Percent Change: -5.28